Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pohl

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Urology|May 1, 1983
Revascularization for preservation of renal function in patients with atherosclerotic renovascular diseaseA C Novick, M A Pohl, M Schreiber, et al.
Nephron|January 1, 1979
Membranous nephropathy: a radioimmunologic search for anti-renal tubular epithelial antibodies and circulating immune complexesR A Zager, W G Couser, B S Andrews, et al.
Cleveland Clinic Quarterly|January 1, 1984
Renal artery stenosis, nephrotic-range proteinuria, and focal and segmental glomerulosclerosisG N Gephardt, R R Tubbs, A C Novick, et al.
JAMA|January 23, 1987
Trends in surgical revascularization for renal artery disease. Ten years' experienceA C Novick, M Ziegelbaum, D G Vidt, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1995
The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study GroupR A Rodby, R D Rohde, Z Sharon, et al.
Kidney International|December 14, 1999
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study GroupD C Cattran, G B Appel, L A Hebert, et al.
Kidney International|March 22, 2001
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trialD C Cattran, G B Appel, L A Hebert, et al.
The New England Journal of Medicine|September 22, 2001
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesE J Lewis, L G Hunsicker, W R Clarke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 1992
Pseudo-gamma heavy chain (IgG4 lambda) deposition diseaseR R Tubbs, V Berkley, R Valenzuela, et al.
Transplantation Proceedings|March 1, 1981
Coronary arteriography and coronary artery disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplantation programsW E Braun, D Phillips, D G Vidt, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Urology|May 1, 1983
Revascularization for preservation of renal function in patients with atherosclerotic renovascular diseaseA C Novick, M A Pohl, M Schreiber, et al.
Nephron|January 1, 1979
Membranous nephropathy: a radioimmunologic search for anti-renal tubular epithelial antibodies and circulating immune complexesR A Zager, W G Couser, B S Andrews, et al.
Cleveland Clinic Quarterly|January 1, 1984
Renal artery stenosis, nephrotic-range proteinuria, and focal and segmental glomerulosclerosisG N Gephardt, R R Tubbs, A C Novick, et al.
JAMA|January 23, 1987
Trends in surgical revascularization for renal artery disease. Ten years' experienceA C Novick, M Ziegelbaum, D G Vidt, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1995
The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study GroupR A Rodby, R D Rohde, Z Sharon, et al.
Kidney International|December 14, 1999
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study GroupD C Cattran, G B Appel, L A Hebert, et al.
Kidney International|March 22, 2001
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trialD C Cattran, G B Appel, L A Hebert, et al.
The New England Journal of Medicine|September 22, 2001
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesE J Lewis, L G Hunsicker, W R Clarke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 1992
Pseudo-gamma heavy chain (IgG4 lambda) deposition diseaseR R Tubbs, V Berkley, R Valenzuela, et al.
Transplantation Proceedings|March 1, 1981
Coronary arteriography and coronary artery disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplantation programsW E Braun, D Phillips, D G Vidt, et al.
Pageof 2